Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Hoa

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Autoimmunity Reviews|May 10, 2021
Histopathological features of systemic sclerosis-associated myopathy: A scoping reviewFrédéric Lefebvre, Margherita Giannini, Benjamin Ellezam, et al.
The Journal of Rheumatology|December 16, 2024
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)Jenny Xiaoyu Li, Marie Hudson, Carrie Ye, et al.
ACR Open Rheumatology|February 18, 2025
Chronicity of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno-Oncology DatabaseAlexandra Ladouceur, Shahin Jamal, Alexandra Saltman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus MethodologyEmily-Ann Butler, Murray Baron, Agnes B Fogo, et al.
ACR Open Rheumatology|April 7, 2026
Clinical Associations of Anti-RNPC3 Autoantibodies in Mixed Connective Tissue DiseaseDarya S Jalaledin, Hajar El Kamouni, Alexandra Albert, et al.
Cancer Immunology, Immunotherapy : CII|January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-OncologySabrina Hoa, Linda Laaouad, Janet Roberts, et al.
Rheumatology Advances in Practice|February 11, 2026
Interstitial lung disease in systemic autoimmune rheumatic diseases: radiologic and histologic correlationsAidan Pye, Darya S Jalaledin, Angela Chang, et al.
Neuropathology and Applied Neurobiology|July 27, 2022
Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositisBenjamin Ellezam, Valérie Leclair, Yves Troyanov, et al.
RMD Open|October 5, 2023
Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotypeHajar El Kamouni, Darya S Jalaledin, Alexandra Albert, et al.
RMD Open|September 6, 2020
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodiesOcéane Landon-Cardinal, Alexandra Baril-Dionne, Sabrina Hoa, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Autoimmunity Reviews|May 10, 2021
Histopathological features of systemic sclerosis-associated myopathy: A scoping reviewFrédéric Lefebvre, Margherita Giannini, Benjamin Ellezam, et al.
The Journal of Rheumatology|December 16, 2024
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)Jenny Xiaoyu Li, Marie Hudson, Carrie Ye, et al.
ACR Open Rheumatology|February 18, 2025
Chronicity of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno-Oncology DatabaseAlexandra Ladouceur, Shahin Jamal, Alexandra Saltman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus MethodologyEmily-Ann Butler, Murray Baron, Agnes B Fogo, et al.
ACR Open Rheumatology|April 7, 2026
Clinical Associations of Anti-RNPC3 Autoantibodies in Mixed Connective Tissue DiseaseDarya S Jalaledin, Hajar El Kamouni, Alexandra Albert, et al.
Cancer Immunology, Immunotherapy : CII|January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-OncologySabrina Hoa, Linda Laaouad, Janet Roberts, et al.
Rheumatology Advances in Practice|February 11, 2026
Interstitial lung disease in systemic autoimmune rheumatic diseases: radiologic and histologic correlationsAidan Pye, Darya S Jalaledin, Angela Chang, et al.
Neuropathology and Applied Neurobiology|July 27, 2022
Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositisBenjamin Ellezam, Valérie Leclair, Yves Troyanov, et al.
RMD Open|October 5, 2023
Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotypeHajar El Kamouni, Darya S Jalaledin, Alexandra Albert, et al.
RMD Open|September 6, 2020
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodiesOcéane Landon-Cardinal, Alexandra Baril-Dionne, Sabrina Hoa, et al.
Pageof 4